Medical Global Academy

Program overview

The Fellowship in Cytopathology is a comprehensive advanced fellowship for 12 months intended for pathologists and pathology trainees who wish to obtain a specialized knowledge of the diagnosis and interpretation of the cytological specimen(s). The programme includes a blend of structured online education, case-based discussions, clinical training, and mentorship from experts, that culminates in the development of advanced skills in the fields of fine needle aspiration cytology (FNAC), exfoliative cytology, gynecologic and non-gynecologic cytology, molecular diagnostics, and digital pathology. The participants are exposed to modern cytopathology techniques, ancillary cytopathology tests, quality assurance, and precision medicine techniques, which are crucial for providing precise, evidence-based cytopathology diagnosis based on international standards.

Skills You Will Gain

  • Advanced knowledge of the principles of cytopathology, specimen processing and diagnostic interpretation.

  • Fine needle aspiration cytology (FNAC) skills and image guided aspiration techniques and sample adequacy assessment skills.

  • Knowledge of exfoliative and liquid-based cytology and cytological staining techniques.

  • Understanding of gynecological cytology, cervical cancer screening, Pap smear reporting and HPV-associated disease assessment.

  • Previous experience in the evaluation of respiratory, urinary, gastrointestinal, breast, endocrine and effusion cytology.

  • Skills in using standardised reporting systems including Bethesda, Milan, Paris and other international classification systems.

  • Knowledge of the technique of immunocytochemistry, flow cytometry, molecular diagnostics, FISH, PCR in cytology.

  • Digital cytopathology, telecytology, AI support to diagnosis and integration of digital workflow.

  • Diagnostic skills for infectious diseases, haematolymphoid lesions, endocrinopathy and complex oncologic diseases using cytology.

  • Understanding of the use of cytopathology in the care of children, transplantation cytology and immunopathology applications.

  • Knowledge of quality control, lab management, reporting requirements, and ethics in pathology.

  • The ability to interpret cytological data in the context of the radiologic, clinical and molecular findings and make a clinical decision.

  • Knowledge of international cytopathology guidelines and updates to WHO classification as well as newly emerging trends in precision oncology.

  • Confidence in dealing with unusual, difficult, and diagnostic challenging cytology cases.

Career Outcomes

  • Work in hospitals, diagnostic centers and pathology labs as a Consultant Cytopathologist.

  • Specialist in Fine Needle Aspiration Cytology (FNAC) and Diagnostic Cytology.

  • A specialist in cancer diagnosis and screening programs.

  • Associate Professor or Staff Doctor of Pathology and Cytopathology.

  • Pathology preceptor or Quality Assurance supervisor.

  • Molecular Cytopathology and Precision Diagnostics Specialist.

  • Digital Pathologist / Telecytology Consultant.

  • Clinical Researcher in Cytopathology, Oncology and Translational Medicine.

  • Experienced in Cervical Cancer Screening and Prevention Oncology Programs.

  • Diagnostic Pathologist in Multi-Disciplinary cancer care teams.

  • Pathology laboratory, diagnostic technology company and health care adviser.

  • Independent Cytopathologist and Advanced Diagnostic Services Consultant.

What you will learn 

Learn from Global Leaders in Cytopathology 

Experience with Advanced Diagnostic Tools 

Cutting-Edge Clinical Exposure in Oncologic Cytology 

Molecular & Ancillary Techniques in Practice 

Cytopathology in Cancer Screening & Early Detection 

Flexible, Hybrid Learning Model 

Quality, Ethics & Leadership in Cytopathology 

Course curriculum

  • History and evolution of cytology
  • Scope and role in modern diagnostics
  • Cytology vs. histopathology
  • Safety and sample handling protocols
  • Basics of microscopy and staining techniques
  • Exfoliative cytology (conventional and liquid-based cytology)
  • Fine Needle Aspiration Cytology (FNAC): techniques, indications, and complications
  • Image-guided FNA (USG/CT-guided) – principles and interpretation
  • Cell block preparation
  • Staining methods (Papanicolaou, Giemsa, H&E, and special stains)
  • Anatomy and physiology of the female reproductive tract
  • Pap smear: collection techniques and reporting
  • The Bethesda System (2025 update) for reporting cervical cytology
  • Screening and management of cervical intraepithelial lesions
  • HPV testing and integration with cytological findings
  • Respiratory tract cytology (sputum, bronchial washings, BAL, FNA)
  • Urinary tract cytology (voided urine, bladder washings)
  • Effusion cytology (pleural, peritoneal, pericardial fluids)
  • Gastrointestinal and hepatobiliary cytology
  • Cerebrospinal fluid cytology
  • Salivary gland and breast cytology
  • Thyroid FNAC – Bethesda System for Reporting Thyroid Cytopathology (TBSRTC 2025)
  • Lymph node FNAC – reactive, granulomatous, and malignant lesions
  • Soft tissue tumors and skin adnexal lesions
  • Bone and cartilage lesions
  • Role of ROSE (Rapid On-Site Evaluation) in FNAC
  • Immunocytochemistry (ICC) – principles and key markers
  • Flow cytometry applications in cytology
  • Molecular diagnostics: PCR, FISH, NGS in cytology
  • Digital pathology and AI in cytological analysis
  • Quality control and standardization in cytopathology labs
  • Unique cytological features in pediatric populations
  • Common pediatric lesions amenable to FNAC
  • Differentiation of benign vs malignant pediatric neoplasms
  • Case-based approach to congenital and developmental conditions
  • Challenges in pediatric sample collection and interpretation
  • Cytological diagnosis of tuberculosis, fungal, and parasitic infections
  • Viral cytopathic effects – CMV, HSV, HPV
  • Cytological findings in HIV-associated conditions
  • Role of cytology in endemic and emerging infectious diseases
  • Integrating microbiology and cytopathology reports
  • Cytology in post-transplant monitoring (e.g., renal, liver, lung)
  • Detection of rejection and infections
  • Cytological evaluation of lymphoproliferative disorders post-transplant
  • Ancillary testing: HLA typing, flow cytometry in transplant cases
  • Digital slide scanning and remote diagnosis
  • Artificial intelligence (AI) in cytopathology – diagnostic aids and challenges
  • Building a digital cytopathology archive
  • Legal, ethical, and regulatory considerations in telepathology
  • Integrating AI into cytology reporting systems
  • Basics of cytogenetic techniques (karyotyping, FISH) in cytology
  • Targeted molecular testing for lung, thyroid, and breast cytology specimens
  • Role of NGS in cytology samples: feasibility and challenges
  • Liquid biopsy and circulating tumor cells (CTCs)
  • Molecular panels and companion diagnostics in precision oncology
  • Image-guided FNAC – ultrasound, CT, and endoscopic ultrasound (EUS)
  • ROSE (Rapid On-Site Evaluation) – logistics and clinical utility
  • Cytopathologist’s role in multidisciplinary interventional teams
  • Biopsy triaging and specimen adequacy assessment
  • Hands-on simulation modules (where available)
  • WHO classification updates (e.g., 2025 tumor classifications)
  • Comparison of global reporting systems: Bethesda, Milan, Paris, Yokohama
  • Cytology practice across different healthcare systems
  • International cytopathology guidelines and consensus statements
  • Preparing for international board certifications or exams
  • Thyroid cytology: benign nodules, neoplasms, and inflammatory lesions
  • Application of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – 2025 update
  • Parathyroid and adrenal gland cytology
  • Diagnostic dilemmas in endocrine FNAs
  • Molecular testing in indeterminate thyroid nodules
  • Cytology of reactive vs neoplastic lymphadenopathy
  • Fine needle aspiration of lymph nodes and bone marrow
  • Role of flow cytometry, immunocytochemistry, and cytogenetics
  • Classification of lymphomas (WHO 2025 update) via cytology
  • Challenges in diagnosing hematolymphoid malignancies in cytologic samples
  • Breast FNAC vs core needle biopsy: indications and limitations
  • Reporting breast cytology using the IAC Yokohama System
  • Benign, atypical, and malignant breast lesions
  • Triple assessment: clinical, radiologic, and cytologic correlation
  • Hormone receptor testing and prognostic markers (ER, PR, HER2) on cell blocks
  • Cytomorphology of benign and malignant soft tissue tumors
  • Role of cytology in sarcoma diagnosis and grading
  • Immunocytochemistry panels for spindle cell and round cell tumors
  • Role of cytogenetics and molecular diagnostics
  • Approach to metastatic bone lesions via cytology
  • Cytological diagnosis of rare neoplasms (e.g., small round blue cell tumors)
  • Cytologic mimics: distinguishing reactive from malignant changes
  • Diagnostic pitfalls and how to avoid them
  • Difficult-to-access organs: pancreas, retroperitoneum, CNS
  • Preparing for expert-level diagnostic boards or panels
  • Cytology of diseases caused by asbestos, silica, and other exposures
  • Evaluation of respiratory samples in occupational lung disease
  • Cytology in screening of industrial workers
  • Role in environmental health surveillance
  • Legal implications of occupational disease diagnosis via cytology
  • Post-mortem cytology: indications and procedures
  • Cytologic evaluation in cause of death investigations
  • Aspiration cytology in suspicious deaths
  • Limitations and ethical considerations
  • Forensic application of cytological findings
Scroll to Top